← Evidence map

ReviewPharmaceutical medicine2020

Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products.

Bryan Newman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32112304